Endologix Inc /DE/ - Current report filing (8-K)
May 28 2008 - 2:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 22, 2008
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-28440
|
|
68-0328265
|
|
|
|
|
|
(State or other
jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
11 Studebaker, Irvine, CA
|
|
92618
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (
949) 595-7200
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
TABLE OF CONTENTS
Item 5.02 Departure of Directors or Certain officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers
(e) On April 9, 2008, the Board of Directors of Endologix, Inc. (the Company) adopted, subject to
stockholder approval, an amendment to the Companys 2006 Employee Stock Purchase Plan (the 2006
Purchase Plan) and an amendment to the Companys 2006 Stock Incentive Plan (the 2006 Plan),
which amendments were approved by the Companys stockholders at the Companys Annual Meeting held
on May 22, 2008. The amendment to the 2006 Purchase Plan increased the authorized number of shares
of the Companys common stock purchasable under the 2006 Purchase Plan by 250,000 shares, or from
308,734 shares to 558,734 shares. The amendment to the 2006 Plan increased the authorized number
of shares of Companys common stock issuable under the 2006 Plan by 3,000,000 shares, or from
2,814,478 shares to 5,814,478 shares.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
ENDOLOGIX, INC.
|
|
May 28, 2008
|
/s/ Robert J. Krist
|
|
|
Robert J. Krist
|
|
|
Chief Financial Officer
|
|
|
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024